3N3G
4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important
Summary for 3N3G
Entry DOI | 10.2210/pdb3n3g/pdb |
Descriptor | Cathepsin S, DI(HYDROXYETHYL)ETHER, DIMETHYL SULFOXIDE, ... (8 entities in total) |
Functional Keywords | cathepsin s, covalent inhibitor, hydrolase |
Biological source | Homo sapiens (human) |
Cellular location | Lysosome: P25774 |
Total number of polymer chains | 2 |
Total formula weight | 49695.70 |
Authors | Fradera, X.,Uitdehaag, J.C.M.,van Zeeland, M. (deposition date: 2010-05-20, release date: 2010-07-14, Last modification date: 2011-07-13) |
Primary citation | Cai, J.,Fradera, X.,van Zeeland, M.,Dempster, M.,Cameron, K.S.,Bennett, D.J.,Robinson, J.,Popplestone, L.,Baugh, M.,Westwood, P.,Bruin, J.,Hamilton, W.,Kinghorn, E.,Long, C.,Uitdehaag, J.C. 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important. Bioorg.Med.Chem.Lett., 20:4507-4510, 2010 Cited by PubMed Abstract: Using computer aided modelling studies, a new extended P2/S2 interaction was identified. This extended region can accommodate a variety of functional groups, such as aryls and basic amines. It was discovered that the N3 nitrogen of the pyrimidine-2-carbonitrile is critical for its cathepsin cysteine protease inhibition. N1 nitrogen also contributes to the inhibitory activity, but to a very limited degree. An 'in situ double activation' mechanism was proposed to explain these results. PubMed: 20580231DOI: 10.1016/j.bmcl.2010.06.043 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report